Category: PMCPA Case of the Week

Cases selected for the AskAnzal weekly PMCPA insight newsletter

8 Mar 2026

Abbott: media report of gay bar visit with consultant led to hospitality complaint (Appeal Board: no breach)

The Sun alleged Abbott reps attended a Glasgow gay bar with a hospital consultant. Panel found hospitality/Clause 2…

8 Mar 2026

Leo Pharma: MSL activity deemed promotional, triggering ABPI exam requirement (AUTH/3244/9/19)

Anonymous employee complaint about Leo’s dermatology MSLs. Panel found some MSL speaker-meeting activity was promotional, so MSLs should…

8 Mar 2026

Britannia Pharmaceuticals: β€œApo-go Pump” branding ruled misleading (AUTH/3377/9/20)

Employee complaint upheld after Britannia used β€œApo-go Pump” name/logo despite Apo-go not being supplied as a pump. Panel…

8 Mar 2026

AUTH/3442/12/20: Complainant v GlaxoSmithKline (LinkedIn pipeline trial posts) – No breach

Complaint alleged GSK promoted unlicensed RSV vaccine and Covid-19 antibody treatment to the public via LinkedIn. Panel ruled…

8 Mar 2026

AUTH/3560/9/21: Anonymous health professional complaint about pressure to sign up to diabetes review service (No breach) – Sanofi

Anonymous nurse alleged a Sanofi account executive pressured them to sign up to a diabetes therapy review service…

8 Mar 2026

AUTH/3482/3/21: Complainant v GlaxoSmithKline (LinkedIn post about Nucala) – Out of scope of the ABPI Code

A complaint alleged promotion of Nucala (mepolizumab) on LinkedIn. The PMCPA recorded the case as outwith the scope…

8 Mar 2026

Tetris Pharma: LinkedIn sponsored message for Ogluo reached a non-HCP (public promotion) and lacked required safety/INN elements

A LinkedIn sponsored message promoting Ogluo (glucagon) was received by a non-HCP. The Panel found public promotion plus…

8 Mar 2026

Ipsen voluntary admission: employee promoted to HCPs in Northern Ireland without verified ABPI representative exam (AUTH/3839/10/23)

Ipsen admitted an employee in a promotional role in Northern Ireland had no verified ABPI representative exam on…

8 Mar 2026

AUTH/3885/3/24: Ever Pharma UK v Britannia Pharmaceuticals – off-licence promotion risk via nurse service package deal and sponsored symposium

PMCPA found Britannia breached Clauses 11.2 and 5.1 after its nurse service package deal agreement contemplated home initiation…

8 Mar 2026

AUTH/2147/7/08: GlaxoSmithKline v Sanofi Pasteur MSD – Gardasil press release and PR agency emails

A Gardasil press release and related PR emails after the UK HPV tender were ruled misleading and exaggerated,…

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training